Fast Market Research

Ocular Therapeutix, Inc. - Product Pipeline Review - 2013 - New Report Available

Recently published research from Global Markets Direct, "Ocular Therapeutix, Inc. - Product Pipeline Review - 2013", is now available at Fast Market Research


Boston, MA -- (SBWIRE) -- 02/03/2014 -- Global Market Direct's pharmaceuticals report, "Ocular Therapeutix, Inc. - Product Pipeline Review - 2013" provides data on the Ocular Therapeutix, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Ocular Therapeutix, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Ocular Therapeutix, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents


- Ocular Therapeutix, Inc. - Brief Ocular Therapeutix, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Ocular Therapeutix, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Ocular Therapeutix, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Ocular Therapeutix, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate Ocular Therapeutix, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Ocular Therapeutix, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Ocular Therapeutix, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Ocular Therapeutix, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Ocular Therapeutix, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Ocular Therapeutix, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Ocular Hypertension - Pipeline Review, H2 2013
- Ocular Hypertension - Pipeline Review, H1 2013
- Bacterial Conjunctivitis - Pipeline Review, H2 2013
- Ocular Inflammation - Pipeline Review, H1 2013
- OPKO Health, Inc. - Product Pipeline Review - 2013
- Bausch & Lomb Incorporated - Product Pipeline Review - 2013
- Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2013
- Novo Nordisk A/S - Product Pipeline Review - 2013
- Parkinson's Disease - Pipeline Review, H1 2013
- Metastatic Pancreatic Cancer - Pipeline Review, H2 2013